Brexit and COVID-19: Changes to the Regulation of Medicines

Published date28 October 2020
Subject MatterUK,Exports,Imports,Licenses,Coronavirus/COVID-19,Applications,New Regulations,Clinical Trials,Medicines and Healthcare Products Regulatory Agency (MHRA),Medical Devices,UK Brexit
AuthorSharon Lamb,Gary Howes,Bella North
Law FirmMcDermott Will & Emery

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT